murine pdac line panc02 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
murine pdac line panc02
Murine Pdac Line Panc02, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 135 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/panc+02+03/Panc+02%2E03/pm42243075-60-13-26
Average 95 stars, based on 135 article reviews
Murine Pdac Line Panc02, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 135 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/panc+02+03/Panc+02%2E03/pm42243075-60-13-26
Average 95 stars, based on 135 article reviews
murine pdac line panc02 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
other:Article Title: Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects Article Snippet: Article Title: Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance Article Snippet: Panc02, PANC-1, MIA PaCa-2, Panc 02.03, and Article Title: De novo pyrimidine biosynthesis inhibition synergizes with BCL-X L targeting in pancreatic cancer Article Snippet: PaTu-8988T and PaTu-8902 cells were obtained from DSMZ, PANC-1, HPAC, Panc 02.03 and Article Title: ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma Article Snippet: Article Title: Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex Article Snippet: PANC-1 (cat. # CRL-1469, RRID:CVCL_0480), Panc 08.13 (cat. # CRL-2551, RRID:CVCL_1638), Panc 02.03 (cat. # CRL-2553, RRID:CVCL_1633), Article Title: De novo pyrimidine biosynthesis inhibition synergizes with BCL-X L targeting in pancreatic cancer Article Snippet: PaTu-8988T and PaTu-8902 cells were obtained from DSMZ (ACC 162 and ACC 179), PANC-1, HPAC, Panc 02.03, and Cell Culture:Article Title: Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade. Article Snippet: .. Human pancreatic cancer cell lines CFPAC- 1, Panc 02.03, and BxPC3 ( Article Title: IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer Article Snippet: KPC cells were cultured in DMEM/F12 medium (Gibco) supplemented with 10% FBS (Gibco), 1% ITS (Beyotime), and 100 U/mL penicillin and streptomycin (Thermo Fisher). .. Other commercially available cell lines were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco) and 100 U/mL penicillin and streptomycin, including |